Homepage

GeneDx Holdings Corp.

WGS NASDAQ Categories PDF
Healthcare · Medical - Healthcare Information Services · United States · Updated May 11, 1:52pm
$39.28
Price
$1.2B
Market Cap
1,000
Employees
2.07
Beta
Katherine A. Stueland
CEO
Business Description

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Business History
Price Overview
Last updated: May 11, 2026 1:52pm (just now)
$39.28
-1.49 (-3.65%)
Day Range
$38.23 – $40.41
52-Week Range
$32.21 – $170.87
50-Day MA
$67.60
200-Day MA
$108.16
Volume
944,646.22
Analyst Price Targets
Low $70.00
Consensus $96.43
High $150.00
(24 analysts)
Share Structure
Outstanding 29,688,000.00
Float 26,005,262.00
Free Float 87.6%
High free float — 87.6% of shares trade freely, ~12.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-53.81
Stock Price: $39.28
EPS (Diluted): -0.73
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
11.35
Stock Price: $39.28
Total Equity: $308.18M
Shares: 26,891,213
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-98.87
Market Cap: $1.17B
Total Debt: $95.90M
Cash: $105.00M
EBITDA: $6.63M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$3.5B
Market Cap: $1.17B
Total Debt: $95.90M
Cash: $105.00M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
69.7%
Gross Profit: $298.17M
Revenue: $427.54M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-2.8%
Operating Income: -$11.80M
Revenue: $427.54M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-4.9%
Net Income: -$21.02M
Revenue: $427.54M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-27.5%
Net Income: -$21.02M
Total Equity: $308.18M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-7.8%
Operating Income: -$11.80M
Tax Rate: 0.5%
Equity: $308.18M
Total Debt: $95.90M
Cash: $105.00M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
2.46
Current Assets: $268.29M
Current Liabilities: $108.91M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.31
Short-Term Debt: $8.95M
Long-Term Debt: $86.95M
Total Debt: $95.90M
Total Equity: $308.18M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$15.90
Revenue: $427.54M
Shares: 26,891,213
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$11.46
Total Equity: $308.18M
Shares: 26,891,213
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$0.53
Operating CF: $33.28M
CapEx: -$19.02M
Shares: 26,891,213
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $39.28
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$21.02M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares WGS against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $212.2M $234.7M $202.6M $305.5M $427.5M
Cost of Revenue $228.8M $261.4M $112.6M $111.1M $129.4M
Gross Profit -$16.6M -$26.8M $90.0M $194.4M $298.2M
Operating Expenses $429.5M $640.9M $270.6M $217.6M $311.3M
Operating Income -$446.1M -$667.7M -$180.6M -$23.2M -$11.8M
Net Income -$245.4M -$549.0M -$175.8M -$52.3M -$21.0M
EBITDA -$220.7M -$398.2M -$136.5M -$1.3M $6.6M
EPS $-74.93 $-53.63 $-7.23 $-1.94 $-0.73
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $400.6M $137.4M $99.7M $85.2M $105.0M
Total Current Assets $483.5M $212.6M $182.3M $198.0M $268.3M
Total Assets $554.1M $545.3M $418.8M $419.4M $570.2M
Current Liabilities $101.3M $144.3M $58.8M $54.8M $108.9M
Long-Term Debt $11.0M $6.3M $52.7M $51.9M $87.0M
Total Liabilities $166.0M $291.6M $190.7M $174.1M $262.0M
Total Equity $388.1M $253.7M $228.0M $245.2M $308.2M
Retained Earnings -$575.4M -$1.1B -$1.3B -$1.4B -$1.4B
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$190.4M -$319.2M -$180.1M -$28.5M $33.3M
Capital Expenditure -$20.8M -$14.3M -$5.7M -$5.5M -$19.0M
Free Cash Flow -$211.2M -$333.5M -$185.9M -$34.0M $14.3M
Acquisitions (net) $0 -$127.0M -$8.1M $0 -$32.9M
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $282.5M -$263.2M -$37.7M -$14.5M $19.8M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $594.1M
$580.5M – $637.4M
 $754.3M
$743.8M – $764.9M
 $888.1M
$867.7M – $952.8M
 $1.2B
$1.1B – $1.2B
EBITDA -$316.3M
-$339.4M – -$309.1M
 -$401.6M
-$407.3M – -$396.0M
 -$472.9M
-$507.3M – -$462.0M
 -$616.3M
-$661.1M – -$602.1M
Net Income $34.2M
$32.1M – $36.2M
 $58.6M
$10.7M – $88.3M
 $106.8M
$103.6M – $116.9M
 $185.4M
$179.9M – $203.0M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +10.6% -13.7% +50.8% +40.0%
Gross Profit Growth -61.1% +436.5% +116.0% +53.4%
Operating Income Growth -49.6% +73.0% +87.1% +49.2%
Net Income Growth -123.7% +68.0% +70.3% +59.8%
EBITDA Growth -80.4% +65.7% +99.1% +625.9%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-04-29 Stueland Katherine M-Exempt 3,874.00 $0.00 $0
2026-04-29 Stueland Katherine S-Sale 2,154.00 $65.20 $140,441
2026-04-29 Stueland Katherine S-Sale 18.00 $64.12 $1,154
2026-04-29 Stueland Katherine M-Exempt 3,874.00 $0.00 $0
2026-04-29 Feeley Kevin M-Exempt 754.00 $0.00 $0
2026-04-29 Feeley Kevin S-Sale 392.00 $65.19 $25,555
2026-04-29 Feeley Kevin M-Exempt 754.00 $0.00 $0
2026-03-26 Feeley Kevin M-Exempt 16,250.00 $0.00 $0
2026-03-26 Feeley Kevin S-Sale 2,485.00 $61.29 $152,308
2026-03-26 Feeley Kevin S-Sale 961.00 $62.33 $59,901
2026-03-26 Feeley Kevin S-Sale 2,520.00 $63.28 $159,463
2026-03-26 Feeley Kevin S-Sale 995.00 $64.60 $64,276
2026-03-26 Feeley Kevin S-Sale 1,857.00 $65.21 $121,103
2026-03-26 Feeley Kevin M-Exempt 16,250.00 $0.00 $0
2026-03-26 Stueland Katherine M-Exempt 80,000.00 $0.00 $0
2026-03-26 Stueland Katherine M-Exempt 80,000.00 $0.00 $0
2026-03-26 Stueland Katherine S-Sale 13,229.00 $61.29 $810,817
2026-03-26 Stueland Katherine S-Sale 5,117.00 $62.33 $318,952
2026-03-26 Stueland Katherine S-Sale 13,412.00 $63.28 $848,699
2026-03-26 Stueland Katherine S-Sale 5,292.00 $64.60 $341,859
Community AI Feedback
Sign in to Contribute
No community reviews yet for WGS. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27